Daniel Davies

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 1K citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 612 citations · Full text

Veterinary Medicine, Immunology, Oncology +14

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Madhumita Shrotri, Maria Krutikov, Tom Palmer et al. · The Lancet Infectious Diseases · 2021 · 193 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study

Maria Krutikov, Tom Palmer, Gokhan Tut et al. · The Lancet Healthy Longevity · 2021 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 69 citations · Full text

Life Sciences, Bioinformatics, Immunology +5